BROOKER CHEMICAL CORPORATION – Trademark Portfolio

Entity Type: 03

BROOKER CHEMICAL CORPORATION holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HORMEX. The owner is based in Chatsworth, CA.

9175 Eton Avenue

Chatsworth, CA 91311

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BROOKER CHEMICAL CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does BROOKER CHEMICAL CORPORATION have?

BROOKER CHEMICAL CORPORATION has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does BROOKER CHEMICAL CORPORATION file in?

BROOKER CHEMICAL CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 21 (Housewares). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are BROOKER CHEMICAL CORPORATION's most well-known trademarks?

BROOKER CHEMICAL CORPORATION's registered trademark portfolio includes well-known marks such as HORMEX. These are among 1 currently registered trademark in the portfolio.

What is BROOKER CHEMICAL CORPORATION's trademark registration success rate?

BROOKER CHEMICAL CORPORATION has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.